JAZZ logo

Jazz Pharmaceuticals (JAZZ) Cash From Operations

Annual CFO

$1.40 B
+$303.90 M+27.83%

December 31, 2024

Summary

Performance

1-Year Change

+27.83%

3-Year Change

+79.31%

5-Year Change

+79.79%

15-Year Change

+101.4%

JAZZ Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

95.79%
JAZZ annual cash flow from operations is higher than 95.79% of companies in Healthcare sector

High & Low

All-time High

$1.40 B
JAZZ annual cash flow from operations is currently at an all-time high

3-Year Low

$778.51 M
JAZZ annual cash flow from operations is currently +79.31% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
JAZZ previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
JAZZ next annual earnings announcement has not yet been scheduled

OtherJAZZcash flowmetrics:

Annual CFI

-$508.19 M
JAZZ annual cash flow from investing activities is -$508.19 million

Annual CFF

$20.52 M
JAZZ annual cash flow from financing activities is $20.52 million

Annual FCF

$1.35 B
JAZZ annual free cash flow is $1.35 billion

Annual CAPEX

$48.07 M
JAZZ annual capital expenditures is $48.07 million

Quarterly CFO

$398.58 M
-$167.00 K-0.04%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

+29.75%

5-Year Change

+29.75%

JAZZ Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

96.02%
JAZZ quarterly cash flow from operations is higher than 96.02% of companies in Healthcare sector

High & Low

All-time High

$417.99 M
JAZZ quarterly cash flow from operations is currently -4.64% below its historical high of $417.99 million

3-Year Low

$167.34 M
JAZZ quarterly cash flow from operations is currently +138.19% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
JAZZ previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 1, 2025
JAZZ next earnings announcement is scheduled for May 1, 2025

OtherJAZZcash flowmetrics:

Quarterly CFI

-$193.29 M
JAZZ quarterly cash flow from investing activities is -$193.29 million

Quarterly CFF

-$8.28 M
JAZZ quarterly cash flow from financing activities is -$8.28 million

Quarterly FCF

$385.29 M
JAZZ quarterly free cash flow is $385.29 million

Quarterly CAPEX

$13.29 M
JAZZ quarterly capital expenditures is $13.29 million

TTM CFO

$1.40 B
+$231.24 M+19.85%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

+10.21%

5-Year Change

+10.21%

JAZZ TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

96.02%
JAZZ TTM cash flow from operations is higher than 96.02% of companies in Healthcare sector

High & Low

All-time High

$1.40 B
JAZZ TTM cash flow from operations is currently at an all-time high

3-Year Low

$702.49 M
JAZZ TTM cash flow from operations is currently +98.71% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
JAZZ previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 1, 2025
JAZZ next earnings announcement is scheduled for May 1, 2025

OtherJAZZcash flowmetrics:

TTM CFI

-$508.19 M
JAZZ TTM cash flow from investing activities is -$508.19 million

TTM CFF

$20.52 M
JAZZ TTM cash flow from financing activities is $20.52 million

TTM FCF

$1.35 B
JAZZ TTM free cash flow is $1.35 billion

TTM CAPEX

$48.07 M
JAZZ TTM capital expenditures is $48.07 million

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

JAZZ Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+27.8%0.0%0.0%
3 y3 years+79.3%+29.8%+10.2%
5 y5 years+79.8%+29.8%+10.2%

JAZZ Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+79.3%-4.6%+138.2%at high+98.7%
5 y5-yearat high+79.8%-4.6%+855.9%at high+98.7%
alltimeall timeat high+1171.9%-4.6%+993.9%at high+1100.6%

Jazz Pharmaceuticals Cash From Operations History

DateAnnualQuarterlyTTM
Dec 2024
$1.40 B(+27.8%)
$398.58 M(-0.0%)
$1.40 B(+19.9%)
Sep 2024
-
$398.75 M(+20.3%)
$1.16 B(+8.5%)
Jun 2024
-
$331.35 M(+24.0%)
$1.07 B(+3.3%)
Mar 2024
-
$267.23 M(+59.7%)
$1.04 B(-4.9%)
Dec 2023
$1.09 B(-14.1%)
$167.34 M(-45.5%)
$1.09 B(-13.8%)
Sep 2023
-
$307.19 M(+3.5%)
$1.27 B(-8.0%)
Jun 2023
-
$296.76 M(-7.5%)
$1.38 B(-0.5%)
Mar 2023
-
$320.71 M(-6.2%)
$1.38 B(+8.8%)
Dec 2022
$1.27 B(+63.4%)
$341.97 M(-18.2%)
$1.27 B(+14.8%)
Sep 2022
-
$417.99 M(+37.9%)
$1.11 B(+14.9%)
Jun 2022
-
$303.04 M(+45.0%)
$963.83 M(+37.2%)
Mar 2022
-
$208.98 M(+17.6%)
$702.49 M(-9.8%)
Dec 2021
$778.51 M(-13.5%)
$177.75 M(-35.1%)
$778.51 M(-1.1%)
Sep 2021
-
$274.06 M(+557.3%)
$787.02 M(+2.1%)
Jun 2021
-
$41.70 M(-85.4%)
$770.85 M(-15.4%)
Mar 2021
-
$285.00 M(+53.0%)
$911.68 M(+1.3%)
Dec 2020
$899.65 M(+15.9%)
$186.27 M(-27.8%)
$899.65 M(+12.3%)
Sep 2020
-
$257.89 M(+41.3%)
$801.17 M(-9.0%)
Jun 2020
-
$182.52 M(-33.1%)
$880.79 M(+4.0%)
Mar 2020
-
$272.97 M(+210.9%)
$847.12 M(+9.1%)
Dec 2019
$776.40 M(-2.8%)
$87.80 M(-74.0%)
$776.40 M(-14.4%)
Sep 2019
-
$337.50 M(+126.7%)
$906.70 M(+14.7%)
Jun 2019
-
$148.85 M(-26.4%)
$790.67 M(-5.2%)
Mar 2019
-
$202.25 M(-7.3%)
$833.80 M(+4.4%)
Dec 2018
$798.90 M(+15.3%)
$218.10 M(-1.5%)
$798.90 M(+1.7%)
Sep 2018
-
$221.47 M(+15.4%)
$785.37 M(+4.3%)
Jun 2018
-
$191.97 M(+14.7%)
$752.79 M(+8.2%)
Mar 2018
-
$167.36 M(-18.2%)
$695.91 M(+0.4%)
Dec 2017
$693.09 M(+17.0%)
$204.56 M(+8.3%)
$693.09 M(+3.6%)
Sep 2017
-
$188.90 M(+39.8%)
$669.22 M(+9.1%)
Jun 2017
-
$135.09 M(-17.9%)
$613.35 M(+1.3%)
Mar 2017
-
$164.54 M(-8.9%)
$605.28 M(+2.2%)
Dec 2016
$592.39 M(+11.4%)
$180.69 M(+35.8%)
$592.39 M(+11.5%)
Sep 2016
-
$133.03 M(+4.7%)
$531.44 M(-7.3%)
Jun 2016
-
$127.01 M(-16.2%)
$573.49 M(-2.3%)
Mar 2016
-
$151.65 M(+26.7%)
$587.04 M(+10.4%)
Dec 2015
$531.94 M
$119.74 M(-31.6%)
$531.94 M(-2.7%)
DateAnnualQuarterlyTTM
Sep 2015
-
$175.08 M(+24.5%)
$546.46 M(+9.1%)
Jun 2015
-
$140.57 M(+45.6%)
$501.08 M(+15.1%)
Mar 2015
-
$96.56 M(-28.1%)
$435.44 M(+6.8%)
Dec 2014
$407.61 M(+41.3%)
$134.26 M(+3.5%)
$407.61 M(+15.7%)
Sep 2014
-
$129.70 M(+73.1%)
$352.38 M(-0.3%)
Jun 2014
-
$74.92 M(+9.0%)
$353.47 M(+23.0%)
Mar 2014
-
$68.72 M(-13.0%)
$287.26 M(-0.4%)
Dec 2013
$288.43 M(+15.5%)
$79.03 M(-39.6%)
$288.43 M(-8.1%)
Sep 2013
-
$130.79 M(+1400.0%)
$313.74 M(+38.2%)
Jun 2013
-
$8.72 M(-87.5%)
$227.10 M(-23.1%)
Mar 2013
-
$69.89 M(-33.0%)
$295.35 M(+18.3%)
Dec 2012
$249.75 M(+64.7%)
$104.34 M(+136.4%)
$249.75 M(+32.1%)
Sep 2012
-
$44.14 M(-42.6%)
$189.07 M(-1.0%)
Jun 2012
-
$76.97 M(+216.8%)
$190.98 M(+26.1%)
Mar 2012
-
$24.30 M(-44.4%)
$151.44 M(-0.1%)
Dec 2011
$151.60 M(+157.5%)
$43.66 M(-5.2%)
$151.60 M(+16.0%)
Sep 2011
-
$46.05 M(+23.0%)
$130.73 M(+26.7%)
Jun 2011
-
$37.44 M(+53.1%)
$103.16 M(+34.3%)
Mar 2011
-
$24.45 M(+7.3%)
$76.82 M(+30.5%)
Dec 2010
$58.87 M(-470.8%)
$22.79 M(+23.3%)
$58.87 M(+55.5%)
Sep 2010
-
$18.49 M(+66.7%)
$37.85 M(+377.8%)
Jun 2010
-
$11.09 M(+70.6%)
$7.92 M(-287.3%)
Mar 2010
-
$6.50 M(+266.8%)
-$4.23 M(-73.4%)
Dec 2009
-$15.88 M(-87.8%)
$1.77 M(-115.5%)
-$15.88 M(-56.4%)
Sep 2009
-
-$11.44 M(+981.5%)
-$36.44 M(-32.1%)
Jun 2009
-
-$1.06 M(-79.5%)
-$53.68 M(-44.8%)
Mar 2009
-
-$5.15 M(-72.6%)
-$97.21 M(-25.4%)
Dec 2008
-$130.23 M(+60.6%)
-$18.79 M(-34.5%)
-$130.23 M(-6.6%)
Sep 2008
-
-$28.69 M(-35.7%)
-$139.51 M(+10.6%)
Jun 2008
-
-$44.59 M(+16.8%)
-$126.19 M(+28.3%)
Mar 2008
-
-$38.17 M(+36.0%)
-$98.35 M(+21.3%)
Dec 2007
-$81.09 M(+41.4%)
-$28.06 M(+82.6%)
-$81.09 M(+52.9%)
Sep 2007
-
-$15.37 M(-8.2%)
-$53.03 M(+40.8%)
Jun 2007
-
-$16.75 M(-19.9%)
-$37.66 M(+80.1%)
Mar 2007
-
-$20.91 M
-$20.91 M
Dec 2006
-$57.35 M(+9.9%)
-
-
Dec 2005
-$52.16 M
-
-

FAQ

  • What is Jazz Pharmaceuticals annual cash flow from operations?
  • What is the all time high annual CFO for Jazz Pharmaceuticals?
  • What is Jazz Pharmaceuticals annual CFO year-on-year change?
  • What is Jazz Pharmaceuticals quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Jazz Pharmaceuticals?
  • What is Jazz Pharmaceuticals quarterly CFO year-on-year change?
  • What is Jazz Pharmaceuticals TTM cash flow from operations?
  • What is the all time high TTM CFO for Jazz Pharmaceuticals?
  • What is Jazz Pharmaceuticals TTM CFO year-on-year change?

What is Jazz Pharmaceuticals annual cash flow from operations?

The current annual CFO of JAZZ is $1.40 B

What is the all time high annual CFO for Jazz Pharmaceuticals?

Jazz Pharmaceuticals all-time high annual cash flow from operations is $1.40 B

What is Jazz Pharmaceuticals annual CFO year-on-year change?

Over the past year, JAZZ annual cash flow from operations has changed by +$303.90 M (+27.83%)

What is Jazz Pharmaceuticals quarterly cash flow from operations?

The current quarterly CFO of JAZZ is $398.58 M

What is the all time high quarterly CFO for Jazz Pharmaceuticals?

Jazz Pharmaceuticals all-time high quarterly cash flow from operations is $417.99 M

What is Jazz Pharmaceuticals quarterly CFO year-on-year change?

Over the past year, JAZZ quarterly cash flow from operations has changed by $0.00 (0.00%)

What is Jazz Pharmaceuticals TTM cash flow from operations?

The current TTM CFO of JAZZ is $1.40 B

What is the all time high TTM CFO for Jazz Pharmaceuticals?

Jazz Pharmaceuticals all-time high TTM cash flow from operations is $1.40 B

What is Jazz Pharmaceuticals TTM CFO year-on-year change?

Over the past year, JAZZ TTM cash flow from operations has changed by $0.00 (0.00%)